Cognitive Behavioral Therapy for Mobile Phone Addiction in Hospitalized Patients

NCT07457658 · tracked via the Priya Life Science China tracker

Sponsor

Sir Run Run Shaw Hospital

Phase

Not applicable

Started

2026-06

Last updated

2026-07-29

Condition(s) studied

Problematic Use of Mobile Phones

Investigational drug(s) / intervention(s)

Cognitive-behavioral therapyTraditional treatment in the ward

Cognitive-behavioral therapy: 5 CBT intervention: the first intervention was conducted after the patient was hospitalized, completed relevant informed consent and pre-test, and lasted for about 30 minutes once; Follow up intervention 4 times: once a day for about 20 minutes. Traditional treatment in the ward includes drug therapy based on the different conditions of hospitalized patients, physical therapy such as work entertainment, Morita, biofeedback therapy, etc. Some patients may also receive transcranial magnetic stimulation therapy and psychological therapy.

Traditional treatment in the ward: Traditional treatment in the ward includes drug therapy based on the different conditions of hospitalized patients, physical therapy such as work entertainment, Morita, biofeedback therapy, etc. Some patients may also receive transcranial magnetic stimulation therapy and psychological therapy.

Study summary

Problematic mobile phone use is excessive dependence and use of electronic products and their functions, which affects the daily life of users. Previous studies have shown that mobile phone addiction is related to depression, anxiety severity, and stress, and it is negatively correlated with sleep quality. For hospitalized patients in the mental health department, symptoms such as anxiety, depression, and poor sleep are very common. Cognitive behavioral therapy has been widely applied in online gaming addiction and is also effective in intervening in mobile phone addiction. Therefore, Hospitalized patients in the mental health department will be randomized to either the CBT interventions or an control group. The main outcome measure is the Simplified Smartphone Addiction Scale (SAS-SV), measured before intervention and after the completion of the last brief intervention.

Eligibility

Sex

ALL

Min age

14 Years

Max age

—

Healthy volunteers

Inclusion Criteria: * Age ≥ 14 years old. * Willingness to treat problematic mobile phone usage behavior. * Voluntarily participate in this study and sign an informed consent form. If the subject is unable to read and sign the informed consent form due to reasons such as lack of legal capacity, or if the subject is a minor, their guardian must act as a proxy for the informed process and sign the informed consent form. If the subject lacks the ability to read the informed consent form (such as illiterate subjects), a witness must witness the informed process and sign the informed consent form. Exclusion Criteria: * Having serious physical or mental illnesses (such as ongoing psychotic symptoms, manic episodes, or severely disabling neurological and psychiatric disorders), unable to cooperate with intervention. * Previously received or currently undergoing CBT intervention for mobile phone addiction. * Cognitive impairment patients, critically ill patients, pregnant women, etc. * There are other situations that researchers consider unsuitable to participate in this study.

Primary outcome measure(s)

Simplified version of the Smartphone Addiction Scale (SAS-SV) — Baseline and Post-intervention (day 5)
The SAS-SV scale was developed by Min Kwon et al. in 2013, consisting of 10 items, and using a 6-level scoring method.

Trial sites (1)

Facility	City	Region	Status
Sir Run Run Shaw Hospital, Zhejiang University School of Medicine	Hangzhou	Zhejiang

More Sir Run Run Shaw Hospital trials in China

Evaluating the Benefits of Personalized Traditional Chinese Medicine in Postoperative Treatment for Locally Advanced Colorectal Cancer Starting soon

Evaluation of the Safety and Efficacy of a Wideband Electric Pulse Tumor Ablation System for Malignant Pulmonary Nodules Active, not recruiting

Effectiveness of Robotic Surgery for Right Colon Cancer Starting soon

The Efficacy and Safety of Neoadjuvant Therapy With Iparomlimab and Tuvonralimab in Locally Advanced MSI-H/dMMR Colorectal Cancer: An Prospective, Single-Arm Study (Neo-IT) Active, not recruiting

Modified Short-Course Radiotherapy Combined With Immunochemotherapy and Targeted Therapy as First-Line Treatment for MSS Metastatic Colorectal Cancer Active, not recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07457658 on ClinicalTrials.gov ↗ ← All trials in China